{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T19:25:53Z","timestamp":1786821953061,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute kidney injury (AKI) is a common and potentially serious complication, yet population-level data on its burden and determinants remain limited. We quantified AKI incidence, temporal trends, and risk factors across a complete healthcare system. We conducted a population-based cohort study including all adult residents of Stockholm, Sweden (2017\u20132021) using the SCREAM project. AKI events requiring hospitalization or occurring during hospital stays were identified using a composite algorithm incorporating laboratory-based KDIGO creatinine criteria, ICD-10 diagnoses, and acute dialysis procedure codes. We calculated annual incidence rates, temporal trends using Poisson regression, and incidence rate ratios for selected demographic, clinical, and laboratory-defined risk factors. Among approximately 1.9 million adults annually, 0.6\u20130.7% experienced AKI each year (71\u201395 per 10,000 person-years). AKI occurred in 5.8\u20137.8% of hospitalizations, with only 30% reaching KDIGO stage 2\u20133. From 2017 to 2021, AKI incidence increased by 26% (95% CI 1.23\u20131.29). Populations at highest risk of AKI were largely consistent over the years, and included older adults, men, and individuals with uncontrolled diabetes, prior AKI, hypertension, heart failure, kidney transplantation, and multiple myeloma. Lower eGFR and higher albuminuria were associated with markedly higher AKI risk in a graded manner. COVID-19 infection was associated with a six-fold higher AKI risk in 2020, but marked attenuation in 2021 suggests it does not explain the overall upward trend. This region-wide analysis quantifies the contemporary burden of AKI and identifies high-risk populations that may benefit from targeted prevention and monitoring strategies.<\/jats:p>","DOI":"10.1038\/s41598-026-67110-y","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T18:43:32Z","timestamp":1786819412000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence, time trends and predictors of acute kidney injury in the region of Stockholm, Sweden"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3908-8206","authenticated-orcid":false,"given":"Jim","family":"Alkas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl-Gustaf","family":"Elinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Barany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvid","family":"Sj\u00f6lander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Jesus","family":"Carrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,15]]},"reference":[{"issue":"1","key":"67110_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1053\/j.ajkd.2016.05.018","volume":"69","author":"S Sawhney","year":"2017","unstructured":"Sawhney, S. et al. Intermediate and long-term outcomes of survivors of acute kidney injury episodes: A large population-based cohort study. Am. J. Kidney Dis. 69 (1), 18\u201328 (2017).","journal-title":"Am. J. Kidney Dis."},{"issue":"11","key":"67110_CR2","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1681\/ASN.2004090740","volume":"16","author":"GM Chertow","year":"2005","unstructured":"Chertow, G. M., Burdick, E., Honour, M., Bonventre, J. V. & Bates, D. W. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J. Am. Soc. Nephrol. 16 (11), 3365\u20133370 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"67110_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00134-023-07314-2","volume":"50","author":"M Meersch","year":"2024","unstructured":"Meersch, M. et al. Acute kidney disease beyond day 7 after major surgery: A secondary analysis of the EPIS-AKI trial. Intensive Care Med. 50 (2), 247\u2013257 (2024).","journal-title":"Intensive Care Med."},{"issue":"2","key":"67110_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.12788\/jhm.2683","volume":"12","author":"SA Silver","year":"2017","unstructured":"Silver, S. A., Long, J., Zheng, Y. & Chertow, G. M. Cost of acute kidney injury in hospitalized patients. J. Hosp. Med. 12 (2), 70\u201376 (2017).","journal-title":"J. Hosp. Med."},{"issue":"1","key":"67110_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12882-023-03396-8","volume":"24","author":"C Monard","year":"2023","unstructured":"Monard, C. et al. Economic burden of in-hospital AKI: a one-year analysis of the nationwide French hospital discharge database. BMC Nephrol. 24 (1), 343 (2023).","journal-title":"BMC Nephrol."},{"issue":"6","key":"67110_CR6","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2215\/CJN.12591117","volume":"13","author":"AS Go","year":"2018","unstructured":"Go, A. S. et al. Acute kidney injury and risk of heart failure and atherosclerotic events. Clin. J. Am. Soc. Nephrol. 13 (6), 833\u2013841 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"67110_CR7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/ki.2011.379","volume":"81","author":"SG Coca","year":"2012","unstructured":"Coca, S. G., Singanamala, S. & Parikh, C. R. Chronic kidney disease after acute kidney injury: A systematic review and meta-analysis. Kidney Int. 81 (5), 442\u2013448 (2012).","journal-title":"Kidney Int."},{"issue":"4","key":"67110_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneph.2017.184","volume":"14","author":"JA Kellum","year":"2018","unstructured":"Kellum, J. A. & Prowle, J. R. Paradigms of acute kidney injury in the intensive care setting. Nat. Rev. Nephrol. 14 (4), 217\u2013230 (2018).","journal-title":"Nat. Rev. Nephrol."},{"issue":"6","key":"67110_CR9","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1053\/j.ajkd.2008.11.034","volume":"53","author":"SG Coca","year":"2009","unstructured":"Coca, S. G., Yusuf, B., Shlipak, M. G., Garg, A. X. & Parikh, C. R. Long-term risk of mortality and other adverse outcomes after acute kidney injury: A systematic review and meta-analysis. Am. J. Kidney Dis. 53 (6), 961\u2013973 (2009).","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"67110_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1001\/archinternmed.2010.514","volume":"171","author":"A Ishani","year":"2011","unstructured":"Ishani, A. et al. The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch. Intern. Med. 171 (3), 226\u2013233 (2011).","journal-title":"Arch. Intern. Med."},{"issue":"23","key":"67110_CR11","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1161\/CIRCULATIONAHA.114.010622","volume":"130","author":"L Ryd\u00e9n","year":"2014","unstructured":"Ryd\u00e9n, L., Sartipy, U., Evans, M. & Holzmann, M. J. Acute kidney injury after coronary artery bypass grafting and long-term risk of end-stage renal disease. Circulation 130 (23), 2005\u20132011 (2014).","journal-title":"Circulation"},{"issue":"6","key":"67110_CR12","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s00134-017-4755-7","volume":"43","author":"R Bellomo","year":"2017","unstructured":"Bellomo, R. et al. Acute kidney injury in sepsis. Intensive Care Med. 43 (6), 816\u2013828 (2017).","journal-title":"Intensive Care Med."},{"issue":"5","key":"67110_CR13","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.jcrc.2014.04.003","volume":"29","author":"MM Sood","year":"2014","unstructured":"Sood, M. M. et al. Early reversible acute kidney injury is associated with improved survival in septic shock. J. Crit. Care. 29 (5), 711\u2013717 (2014).","journal-title":"J. Crit. Care"},{"key":"67110_CR14","first-page":"7698090","volume":"2018","author":"C Rimes-Stigare","year":"2018","unstructured":"Rimes-Stigare, C. et al. Creatinine- and cystatin C-based incidence of chronic kidney disease and acute kidney disease in AKI survivors. Crit. Care Res. Pract. 2018, 7698090 (2018).","journal-title":"Crit. Care Res. Pract."},{"issue":"4","key":"67110_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1053\/j.ajkd.2015.02.337","volume":"66","author":"ME Grams","year":"2015","unstructured":"Grams, M. E. et al. A meta-analysis of the association of estimated GFR, albuminuria, age, race, and sex with acute kidney injury. Am. J. Kidney Dis. 66 (4), 591\u2013601 (2015).","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"67110_CR16","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1053\/j.ajkd.2015.02.338","volume":"66","author":"MT James","year":"2015","unstructured":"James, M. T. et al. A meta-analysis of the association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with acute kidney injury. Am. J. Kidney Dis. 66 (4), 602\u2013612 (2015).","journal-title":"Am. J. Kidney Dis."},{"issue":"9","key":"67110_CR17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41581-021-00418-2","volume":"17","author":"JR Prowle","year":"2021","unstructured":"Prowle, J. R. et al. Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the acute disease quality initiative and perioperative quality initiative. Nat. Rev. Nephrol. 17 (9), 605\u2013618 (2021).","journal-title":"Nat. Rev. Nephrol."},{"issue":"6","key":"67110_CR18","first-page":"548","volume":"17","author":"N Srisawat","year":"2011","unstructured":"Srisawat, N. & Kellum, J. A. Acute kidney injury: definition, epidemiology, and outcome. Curr. Opin. Crit. Care. 17 (6), 548\u2013555 (2011).","journal-title":"Curr. Opin. Crit. Care"},{"issue":"1","key":"67110_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12882-017-0487-8","volume":"18","author":"J Koeze","year":"2017","unstructured":"Koeze, J. et al. Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria. BMC Nephrol. 18 (1), 70 (2017).","journal-title":"BMC Nephrol."},{"issue":"6","key":"67110_CR20","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.kint.2022.02.033","volume":"101","author":"S Sawhney","year":"2022","unstructured":"Sawhney, S. et al. Harmonization of epidemiology of acute kidney injury and acute kidney disease produces comparable findings across four geographic populations. Kidney Int. 101 (6), 1271\u20131281 (2022).","journal-title":"Kidney Int."},{"issue":"3","key":"67110_CR21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1053\/j.ajkd.2023.01.448","volume":"82","author":"CJ Diamantidis","year":"2023","unstructured":"Diamantidis, C. J. et al. Epidemiology of community-acquired acute kidney injury among US veterans. Am. J. Kidney Dis. 82 (3), 300\u2013310 (2023).","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"67110_CR22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.kint.2017.03.020","volume":"92","author":"K Kashani","year":"2017","unstructured":"Kashani, K. et al. No increase in the incidence of acute kidney injury in a population-based annual temporal trends epidemiology study. Kidney Int. 92 (3), 721\u2013728 (2017).","journal-title":"Kidney Int."},{"issue":"3","key":"67110_CR23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/joim.13418","volume":"291","author":"JJ Carrero","year":"2022","unstructured":"Carrero, J. J. & Elinder, C. G. The Stockholm CREAtinine Measurements (SCREAM) project: Fostering improvements in chronic kidney disease care. J. Intern. Med. 291 (3), 254\u2013268 (2022).","journal-title":"J. Intern. Med."},{"issue":"9","key":"67110_CR24","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150 (9), 604\u2013612 (2009).","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"67110_CR25","doi-asserted-by":"publisher","first-page":"426","DOI":"10.7326\/M20-0529","volume":"173","author":"K Sumida","year":"2020","unstructured":"Sumida, K. et al. Conversion of urine protein-creatinine ratio or urine dipstick protein to urine albumin-creatinine ratio for use in chronic kidney disease screening and prognosis: An individual participant-based meta-analysis. Ann. Intern. Med. 173 (6), 426\u2013435 (2020).","journal-title":"Ann. Intern. Med."},{"issue":"4S","key":"67110_CR26","first-page":"S117","volume":"105","author":"Kidney Disease","year":"2024","unstructured":"Kidney Disease. Improving global outcomes CKDWG. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 105 (4S), S117\u2013S314 (2024).","journal-title":"Kidney Int."},{"issue":"2","key":"67110_CR27","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1053\/j.ajkd.2023.07.015","volume":"83","author":"S Brar","year":"2024","unstructured":"Brar, S. et al. Processes of care after hospital discharge for survivors of acute kidney injury: A population-based cohort study. Am. J. Kidney Dis. 83 (2), 216\u2013228 (2024).","journal-title":"Am. J. Kidney Dis."},{"issue":"12","key":"67110_CR28","doi-asserted-by":"publisher","first-page":"e2450014","DOI":"10.1001\/jamanetworkopen.2024.50014","volume":"7","author":"V Mahalingasivam","year":"2024","unstructured":"Mahalingasivam, V. et al. Kidney function decline after COVID-19 infection. JAMA Netw. Open. 7 (12), e2450014 (2024).","journal-title":"JAMA Netw. Open."},{"issue":"4","key":"67110_CR29","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja, A. Kidney disease improving global outcomes (KDIGO) clinical practice guidelines for acute kidney injury. Nephron Clin. Pract. 120 (4), c179\u2013c184 (2012).","journal-title":"Nephron Clin. Pract."},{"key":"67110_CR30","unstructured":"A. A. Categorical Data Analysis. 3rd ed. ed: Wiley; (2013)."},{"issue":"9","key":"67110_CR31","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.2215\/CJN.00710113","volume":"8","author":"P Susantitaphong","year":"2013","unstructured":"Susantitaphong, P. et al. World incidence of AKI: a meta-analysis. Clin. J. Am. Soc. Nephrol. 8 (9), 1482\u20131493 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"23","key":"67110_CR32","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1161\/CIRCULATIONAHA.114.010622","volume":"130","author":"L Ryden","year":"2014","unstructured":"Ryden, L., Sartipy, U., Evans, M. & Holzmann, M. J. Acute kidney injury after coronary artery bypass grafting and long-term risk of end-stage renal disease. Circulation 130 (23), 2005\u20132011 (2014).","journal-title":"Circulation"},{"issue":"12","key":"67110_CR33","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00134-023-07169-7","volume":"49","author":"A Zarbock","year":"2023","unstructured":"Zarbock, A. et al. Epidemiology of surgery associated acute kidney injury (EPIS-AKI): A prospective international observational multi-center clinical study. Intensive Care Med. 49 (12), 1441\u20131455 (2023).","journal-title":"Intensive Care Med."},{"issue":"6","key":"67110_CR34","doi-asserted-by":"publisher","first-page":"e019435","DOI":"10.1136\/bmjopen-2017-019435","volume":"8","author":"S Sawhney","year":"2018","unstructured":"Sawhney, S. et al. Acute kidney injury in the UK: A replication cohort study of the variation across three regional populations. BMJ Open. 8 (6), e019435 (2018).","journal-title":"BMJ Open."},{"issue":"1","key":"67110_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.xkme.2020.11.008","volume":"3","author":"SA Silver","year":"2021","unstructured":"Silver, S. A. et al. The prevalence of acute kidney injury in patients hospitalized with COVID-19 infection: A systematic review and meta-analysis. Kidney Med. 3 (1), 83\u201398 (2021). e1.","journal-title":"Kidney Med."},{"issue":"6","key":"67110_CR36","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41581-024-00823-3","volume":"20","author":"RK Hall","year":"2024","unstructured":"Hall, R. K. et al. Drug stewardship in chronic kidney disease to achieve effective and safe medication use. Nat. Rev. Nephrol. 20 (6), 386\u2013401 (2024).","journal-title":"Nat. Rev. Nephrol."},{"issue":"2","key":"67110_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/ckj\/sfz113","volume":"13","author":"HO Hounkpatin","year":"2020","unstructured":"Hounkpatin, H. O. et al. The association of socioeconomic status with incidence and outcomes of acute kidney injury. Clin. Kidney J. 13 (2), 245\u2013252 (2020).","journal-title":"Clin. Kidney J."},{"issue":"3","key":"67110_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41581-025-01030-4","volume":"22","author":"J Cerda","year":"2026","unstructured":"Cerda, J. et al. The global epidemiology of acute kidney injury: challenges and opportunities. Nat. Rev. Nephrol. 22 (3), 179\u2013198 (2026).","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"67110_CR39","doi-asserted-by":"publisher","first-page":"682","DOI":"10.2215\/CJN.07650713","volume":"9","author":"ME Grams","year":"2014","unstructured":"Grams, M. E. et al. Performance and limitations of administrative data in the identification of AKI. Clin. J. Am. Soc. Nephrol. 9 (4), 682\u2013689 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"67110_CR40","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s40620-022-01505-8","volume":"36","author":"J Alkas","year":"2023","unstructured":"Alkas, J. et al. Novel glucose-lowering drugs and the risk of acute kidney injury in routine care; the Stockholm CREAtinine Measurements (SCREAM) project. J. Nephrol. 36 (3), 705\u2013711 (2023).","journal-title":"J. Nephrol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-67110-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-67110-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-67110-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T18:49:35Z","timestamp":1786819775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-67110-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67110"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-67110-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,15]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors have no conflict of interest to report in relation to the topic of this study. Unrelated to the study, JJC reports funding to Karolinska Institutet by AstraZeneca, Boehringer Ingelheim, Vifor Pharma, NovoNordisk and MSD, as well as personal honoraria for lectures by Fresenius Kabi, Laboratorios Columbia and ERN.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25525"}}